» Articles » PMID: 14735200

Germline Mutations of the INK4a-ARF Gene in Patients with Suspected Genetic Predisposition to Melanoma

Overview
Journal Br J Cancer
Specialty Oncology
Date 2004 Jan 22
PMID 14735200
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Germline anomalies of the INK4a-ARF and Cdk4 genes were sought in a series of 89 patients suspected of having a genetic predisposition to melanoma. Patients were selected based on the following criteria: (a) familial melanoma (23 cases), (b) multiple primary melanoma (MPM; 18 cases), (c) melanoma and additional unrelated cancers (13 cases), (d) age at diagnosis less than 25 years (21 cases), and (e) nonphoto-induced melanoma (NPIM; 14 cases). Mutations of INK4a-ARF and Cdk4 were characterised by automated sequencing, and germline deletions of INK4a-ARF were also examined by real-time quantitative PCR. Seven germline changes of INK4a-ARF, five of which were novel, were found in seven patients (8%). Four were very likely to be pathogenic mutations and were found in three high-risk melanoma families and in a patient who had a pancreatic carcinoma in addition to melanoma. Three variants of uncertain significance were detected in one MPM patient, one patient <25 years, and one NPIM patient. No germline deletion of INK4a-ARF was found in 71 patients, and no Cdk4 mutation was observed in the 89 patients. This study confirms that INK4a-ARF mutations are infrequent outside stringent familial criteria, and that germline INK4a-ARF deletions are rarely involved in genetic predisposition to melanoma.

Citing Articles

Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review.

Pantaleo A, Forte G, Fasano C, Lepore Signorile M, Sanese P, De Marco K Cancers (Basel). 2024; 16(1).

PMID: 38201484 PMC: 10778202. DOI: 10.3390/cancers16010056.


Germline mutations predisposing to melanoma.

Toussi A, Mans N, Welborn J, Kiuru M J Cutan Pathol. 2020; 47(7):606-616.

PMID: 32249949 PMC: 8232041. DOI: 10.1111/cup.13689.


Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations.

McWilliams R, Wieben E, Chaffee K, Antwi S, Raskin L, Olopade O Cancer Epidemiol Biomarkers Prev. 2018; 27(11):1364-1370.

PMID: 30038052 PMC: 6214745. DOI: 10.1158/1055-9965.EPI-17-1065.


Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Low to Moderate Incidence: The Rule of 2 vs the Rule of 3.

Delaunay J, Martin L, Bressac-de Paillerets B, Duru G, Ingster O, Thomas L JAMA Dermatol. 2017; 153(11):1122-1129.

PMID: 28903138 PMC: 5710425. DOI: 10.1001/jamadermatol.2017.2926.


Germline BAP1 alterations in familial uveal melanoma.

Rai K, Pilarski R, Boru G, Rehman M, Saqr A, Massengill J Genes Chromosomes Cancer. 2016; 56(2):168-174.

PMID: 27718540 PMC: 5490375. DOI: 10.1002/gcc.22424.


References
1.
Bastiaens M, ter Huurne J, Gruis N, Bergman W, Westendorp R, Vermeer B . The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet. 2001; 10(16):1701-8. DOI: 10.1093/hmg/10.16.1701. View

2.
Monzon J, Liu L, Brill H, Goldstein A, Tucker M, From L . CDKN2A mutations in multiple primary melanomas. N Engl J Med. 1998; 338(13):879-87. DOI: 10.1056/NEJM199803263381305. View

3.
Rizos H, Puig S, Badenas C, Malvehy J, Darmanian A, Jimenez L . A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene. 2001; 20(39):5543-7. DOI: 10.1038/sj.onc.1204728. View

4.
Auroy S, Avril M, Chompret A, Pham D, Goldstein A, Bianchi-Scarra G . Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect. Genes Chromosomes Cancer. 2001; 32(3):195-202. DOI: 10.1002/gcc.1183. View

5.
Becker T, Rizos H, Kefford R, Mann G . Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding. Clin Cancer Res. 2001; 7(10):3282-8. View